Apollo Health Ventures — Full Portfolio

Booster Therapeutics develops small-molecule medicines that directly activate the cell's 20S proteasome to restore protein quality-control and clear disease-causing proteins, using its structure-based DGRADX platform combining high-throughput screening, X-ray crystallography, and computational tools.

BiotechDeep TechLongevity

DRDiogo R. Feleciano(Co-Founder & CSO)inDJDarci J. Trader(Scientific Co-Founder / Advisor)JRJoão Ribas(Interim-CBO)in

Co-investorsNONovo HoldingsKOKorify Capital

HAYA Therapeutics develops precision RNA medicines that target long non-coding RNAs (lncRNAs) in the regulatory genome to reprogram disease at the level of cell state, with a lead program in cardiac fibrosis and work in obesity and metabolic disease.

AI & Machine LearningBiotechDeep TechHealthtech

SOSamir Ounzain(Chief Executive Officer (CEO) & Co-founder)inDBDaniel Blessing(Chief Scientific Officer (CSO) & Co-founder)inRLRichard Law(Chief Business Officer (CBO))inEAEric Adam(Chief Operating Officer (COO))inJSJordan Shin(Chief Medical Officer (CMO))inJAJérôme Andries(Chief Financial Officer (CFO))in

Co-investorsBRBroadview VenturesSOSofinnova Partners+N+ND Capital4S4see VenturesLILifelinkHUHumboldt

Samsara Therapeutics develops small-molecule therapeutics that activate autophagy to slow the progression of age-related neurodegenerative diseases such as ALS, Parkinson's, and Charcot-Marie-Tooth disease.

BiotechDeep TechLongevityBoston, US

Co-investorsAHAHO Beratung Gmb HCOCoastCapFEFelix JahnFJFJ LabsKOKorify CapitalANAndreessen Horowitz+2 more

Abalos Therapeutics develops immunotherapy treatments using arenavirus-based approaches for cancer.

BiotechHealthtech

Co-investorsCOcoparionVEVentura BioMed InvestorsBOBoehringer Ingelheim Venture Fund

Aeovian Pharmaceuticals is a clinical-stage biopharmaceutical company developing selective small molecule inhibitors to treat rare genetic and age-related diseases caused by dysregulated cellular metabolism.

BiotechBerkeley, US

Allison J. Hulme(CEO & President)inJKJohn Kincaid(Chief Scientific Officer)inDRDavis Ryman(Executive Officer)inMZMicah Zajic(Executive Officer)inIan Massey(Executive Officer)Stelios Tzannis(Executive Officer, Director)

Co-investorsCOCoastCapCTCTI Life Sciences Fund L.P.FEFelix JahnFJFJ LabsLULuma GroupSOSofinnova Ventures+2 more

BiotechNewton, US

Katharine Yen(Executive Officer, Director)KYKate Yen(Founder)inChristopher Guiffre(Executive Officer)

BoardAlon Lazarus(Director)AFAnna French(Director)inACAlexandra Cantley(Director)in

Co-investorsDCDCVC (Data Collective)QIQiming Venture Partners USABRBrightEdgeDCDCVC BioPOPolaris PartnersQIQiming Venture Partners

Bloom Science is a clinical-stage biotech company developing live biotherapeutic products that replicate the effects of the ketogenic diet through the gut-brain axis.

BiotechDeep TechDigital HealthSan Diego, US

Co-investorsALALS Investment FundJOJoyance PartnersPSPsyMed VenturesSOSocial StartsLELeaps by Bayer

Cleara Biotech develops compounds to eliminate senescent cells for treating late-stage cancer and chronic age-related diseases.

BiotechDeep TechHealthtechLongevityMedical DevicesUtrecht, NL

PDPeter de Keizer(Founder and Managing Director)inTMTobias Madl(Head of Structural Biology, Scientific Co-founder)

Co-investorsCOCoastCapCUCurie CapitalFJFJ LabsKOKorify CapitalKUKurma PartnersROROM Utrecht Region

Cognito is a Canadian online mental health service offering cognitive behavioral therapy and psychiatric care for anxiety, depression, insomnia, and ADHD.

Digital HealthHealthtechMental HealthVictoria, CA

Co-investorsGAGarage CapitalGRGraphite VenturesSISimplex VenturesIAIAG Capital Partners

Interviewed provides job simulations and assessments that let employers evaluate candidates' performance on job-related tasks.

Enterprise SoftwareHR TechAustin, US

CBChris Bakke(Founder)inDNDarren Nix(Founder)inDODaniel O'Shea(Founder)inRCRyan Choi(Advisor/Investor)in

Co-investorsFUFundersClubSOSocial StartsSWSwitch VenturesY Y CombinatorGRGreat Oaks Venture CapitalJOJoyance Partners+8 more

BiotechSt. Petersburg, US

CSChristopher Shepard(Executive Officer, Director)inJarod Rutledge(Director)

BoardNRNils Regge(Director)in

Co-investorsKOKorify Capital

Ochre Bio develops RNA therapeutics and drug discovery platforms targeting liver disease, combining proprietary human liver datasets with AI-driven causal prediction and human tissue validation models.

AI & Machine LearningBiotechHealthtechMedical DevicesLondon, GB

QWQuin Wills(Founder & CEO)inJOJack O'Meara(Founder)in

BoardChinwe UkomaduElaine SullivanEliot ForsterJack Castle

Co-investorsBABackedBEBeast VenturesCOCoastCapENEntrepreneur FirstEXExpaGAGaingels+18 more

Refoxy is a science-driven company focused on drug discovery, medicinal chemistry, and bioinformatics.

BiotechDeep TechHealthtechLongevity

VBVictor Bustos(Co-Founder & CEO)inWLWolfgang Link(Scientific Co-founder & Advisor)inAPAndrew Pierce(Chief Science Officer)in

Co-investorsKOKorify CapitalBOBoehringer Ingelheim Venture FundCOcoparionHTHTGF

Scripta Therapeutics is a drug discovery company that maps and modulates transcription factors using AI/ML models and patient-derived disease models to identify novel therapeutics.

AI & Machine LearningBiotechDeep Tech

Co-investorsALAlbionVCOXOxford Science Enterprises

Tacalyx develops novel anticancer therapeutics that target Tumor-Associated Carbohydrate Antigens (TACAs), including antibody-drug conjugate programs.

BiotechDeep TechMedical DevicesBerlin, DE

Peter Seeberger(Co-founder (Prof. Dr.))Oren Moscovitz(CSO & Co-founder)

Co-investorsCOcoparionCRCreathor VenturesKUKurma PartnersBOBoehringer Ingelheim Venture FundTHThuja Capital

Therini Bio is a biotechnology company developing fibrin-targeting therapeutics to treat neurological and ophthalmological diseases, leveraging scientific discoveries in neurovascular and neuroimmune mechanisms of disease.

BiotechDigital HealthHealthtechMedical DevicesSacramento, US

KAKaterina Akassoglou(Scientific Founder, Director of the Center for Neurovascular Brain Immunology and Professor of Neurology at UCSF and Gladstone Institutes)inKAKaterina Akassoglou, PhD(Scientific Founder)LSLeslie Schulze(Executive Officer)TNTara Nickerson(Executive Officer, Director)in

BoardODOlga Danilchanka(Director)inLaia Crespo-Martin(Director)

Co-investorsMRMRL Ventures FundSASanofi VenturesSVSV Health InvestorsANAngelini VenturesDEDementia Discovery FundDODolby Family Ventures+2 more

Tubulis develops antibody-drug conjugates (ADCs) for cancer treatment, using proprietary conjugation platform technologies to create tumor-targeting therapeutics.

BiotechDeep TechMedical DevicesPlanegg-Martinsried, DE

DSDominik Schumacher(Co-founder & CEO)inJonas Helma-Smets(Co-founder & Chief Scientific Officer)Christian Hackenberger(Scientific Co-founder)

Co-investorsANAndera PartnersBIBioMedPartnersEQEQT Life SciencesNENexTech VenturesASAscenta CapitalBABayern Kapital+8 more

Vandria is a pharmaceutical development company focused on translating scientific innovation into first-in-class therapeutics.

BiotechHealthtechLongevityMedical DevicesLausanne, CH

PAPatrick Aebischer(Co-founder)Pénélope Andreux(Head of Research (mitochondrial research and development))inKDKlaus Dugi(Chief Medical Officer / Medical Leadership)inPeter(Business Development & Entrepreneurship Leadership)Leila(Operations Leadership)Anke Post(Chief Medical Officer / Neuroscience Leadership)

Co-investors+N+ND CapitalDODolby Family VenturesLELevensohn Venture Partners